Weekly Recap: Term Loan B restructured and $337 target for JAZZ
Jazz Pharmaceuticals Public Limited Company (NASDAQ:JAZZ) restructured its Term Loan B—issuing Tranche B-3 due May 5, 2033, repriced to SOFR+1.75% with a 0.50% floor and 0.25% quarterly amortization while borrowing ~$273.3M—while Goldman Sachs set a $337 price target.Previous Week RecapThis is an A…